1. Market Research
  2. > Helix BioMedix, Inc. - Product Pipeline Review - 2013

Helix BioMedix, Inc. - Product Pipeline Review - 2013

  • December 2013
  • -
  • Global Markets Direct
  • -
  • 28 pages

Helix BioMedix, Inc. - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “Helix BioMedix, Inc. - Product Pipeline Review - 2013” provides data on the Helix BioMedix, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Helix BioMedix, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Helix BioMedix, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Helix BioMedix, Inc. - Brief Helix BioMedix, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Helix BioMedix, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Helix BioMedix, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Helix BioMedix, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Helix BioMedix, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Helix BioMedix, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Helix BioMedix, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Helix BioMedix, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Helix BioMedix, Inc. and identify potential opportunities in those areas.

Table Of Contents

Helix BioMedix, Inc. - Product Pipeline Review - 2013
Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
Helix BioMedix, Inc. Snapshot 4
Helix BioMedix, Inc. Overview 4
Key Information 4
Key Facts 4
Helix BioMedix, Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
Helix BioMedix, Inc. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Helix BioMedix, Inc. - Pipeline Products Glance 9
Helix BioMedix, Inc. - Early Stage Pipeline Products 9
Preclinical Products/Combination Treatment Modalities 9
Helix BioMedix, Inc. - Unknown Stage Pipeline Products 10
Unknown Products/Combination Treatment Modalities 10
Helix BioMedix, Inc. - Drug Profiles 11
HB-1275 11
Product Description 11
Mechanism of Action 11
RandD Progress 11
HB-1345 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
HB-2031 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
HB-2032 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
HB-2081 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
HB-802 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
Helix BioMedix, Inc. - Pipeline Analysis 17
Helix BioMedix, Inc. - Pipeline Products by Therapeutic Class 17
Helix BioMedix, Inc. - Pipeline Products by Target 18
Helix BioMedix, Inc. - Pipeline Products by Route of Administration 19
Helix BioMedix, Inc. - Pipeline Products by Molecule Type 20
Helix BioMedix, Inc. - Dormant Projects 21
Helix BioMedix, Inc. - Company Statement 22
Helix BioMedix, Inc. - Locations And Subsidiaries 26
Head Office 26
Appendix 27
Methodology 27
Coverage 27
Secondary Research 27
Primary Research 27
Expert Panel Validation 27
Contact Us 28
Disclaimer 28



List of Tables

Helix BioMedix, Inc., Key Information 4
Helix BioMedix, Inc., Key Facts 4
Helix BioMedix, Inc. - Pipeline by Indication, 2013 6
Helix BioMedix, Inc. - Pipeline by Stage of Development, 2013 7
Helix BioMedix, Inc. - Monotherapy Products in Pipeline, 2013 8
Helix BioMedix, Inc. - Preclinical, 2013 9
Helix BioMedix, Inc. - Unknown, 2013 10
Helix BioMedix, Inc. - Pipeline by Therapeutic Class, 2013 17
Helix BioMedix, Inc. - Pipeline by Target, 2013 18
Helix BioMedix, Inc. - Pipeline by Route of Administration, 2013 19
Helix BioMedix, Inc. - Pipeline by Molecule Type, 2013 20
Helix BioMedix, Inc. - Dormant Developmental Projects,2013 21



List of Figures

Helix BioMedix, Inc. - Pipeline by Top 10 Indication, 2013 6
Helix BioMedix, Inc. - Pipeline by Stage of Development, 2013 7
Helix BioMedix, Inc. - Monotherapy Products in Pipeline, 2013 8
Helix BioMedix, Inc. - Pipeline by Top 10 Therapeutic Class, 2013 17
Helix BioMedix, Inc. - Pipeline by Top 10 Route of Administration, 2013 19
Helix BioMedix, Inc. - Pipeline by Top 10 Molecule Type, 2013 20



Companies Mentioned

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.